PSMA x CD3
Assets acting on this target.
- Class
- Protease-activated PSMA x CD3 T-cell engager
By indication
Related mechanisms
PSMA x CD3 drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Olsutamig | Regeneron Pharmaceuticals | bispecific antibody | Phase 1/2 | Phase 1/2 in Prostate Cancer |
| JANX007 | Janux Therapeutics | bispecific antibody | Phase 1 | Phase 1 in Prostate Cancer |
| VIR-5500 | Astellas Pharma | bispecific antibody (T-cell engager) | Phase 1 | Phase 1 in Prostate Cancer |